Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

Why this paper is included

Supporting source evidence:

Concerning the effect of nutrition on bone health, insufficient evidence was found to determine the effect of oral protein supplementation on functional outcomes in people following hip fracture68 while vitamin D (800 IU) and calcium (1000 mg) supplementation in older people with a history of osteoporotic fracture appeared generally ineffective in preventing future hip or any new fracture.69 One RCT, at low risk of bias, investigated the effect of a single loading dose of vitamin D3 compared with a placebo injection administered to older people within 7 days of hip fracture surgery.70 At 4 weeks there was no statistically significant between-group difference in fracture incidence, but the falls rate of participants in the active group was 250 (number of falls/days x 1000) compared with 821.4 in the placebo group (absolute risk reduction 57.1%).

Source: Point to consider 5: exercise and nutritional interventions for patients who have experienced a fragility fracture. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Study design awaiting verification.

Study design awaiting verification

The available source does not establish a sufficiently clear study design.

Meta-analysis unclear · Blinding unclear / not reported · Research setting awaiting verification

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

2019 EULAR points to consider for non-physician health professionals to prevent and manage fragility fractures in adults 50 years or older

Study design awaiting verification · Annals of the Rheumatic Diseases · 2021

Original publication title

2019 EULAR points to consider for non-physician health professionals to prevent and manage fragility fractures in adults 50 years or older

Jo Adams; Nicky Wilson; Emalie Hurkmans; Margot Bakkers; Petra Balážová; Mark Baxter; Anne-Birgitte Blavnsfeldt; Karine Briot; Catharina Chiari; Cyrus Cooper; Razvan Gabriel Dragoi; Gabriele Gäbler; Willem Lems; Erika Mosor; Sandra Pais; Cornelia Simon; Paul Studenic; Simon Tilley; Jenny de la Torre-Aboki; Tanja A Stamm

© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY. Published by BMJ.

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

These first EULAR points to consider for non-physician health professionals to prevent and manage fragility fractures in adults 50 years or older serve to guide healthcare practice and education.

An extract from the source publication. Read it in context.

At a glance

Abstract: What objectives does the paper state?

To establish European League Against Rheumatism (EULAR) points to consider for non-physician health professionals to prevent and manage fragility fractures in adults 50 years or older.

Source: Objective

Abstract: What methods does the paper describe?

Points to consider were developed in accordance with EULAR standard operating procedures for EULAR-endorsed recommendations, led by an international multidisciplinary task force, including patient research partners and different health professionals from 10 European countries. Level of evidence and strength of recommendation were determined for each point to consider, and the mean level of agreement among the task force members was calculated.

Source: Methods

Abstract: Results

Two overarching principles and seven points to consider were formulated based on scientific evidence and the expert opinion of the task force. The two overarching principles focus on shared decisions between patients and non-physician health professionals and involvement of different non-physician health professionals in prevention and management of fragility fractures. Four points to consider relate to prevention: identification of patients at risk of fracture, fall risk evaluation, multicomponent interventions to prevent primary fracture and discouragement of smoking and overuse of alcohol.

The remaining three focus on management of fragility fractures: exercise and nutritional interventions, the organisation and coordination of multidisciplinary services for post-fracture models of care and adherence to anti-osteoporosis medicines. The mean level of agreement among the task force for the overarching principles and the points to consider ranged between 8.4 and 9.6.

Source: Results

Abstract: Conclusion

These first EULAR points to consider for non-physician health professionals to prevent and manage fragility fractures in adults 50 years or older serve to guide healthcare practice and education.

Source: Conclusion
Authors’ abstract

Objective

To establish European League Against Rheumatism (EULAR) points to consider for non-physician health professionals to prevent and manage fragility fractures in adults 50 years or older.

Methods

Points to consider were developed in accordance with EULAR standard operating procedures for EULAR-endorsed recommendations, led by an international multidisciplinary task force, including patient research partners and different health professionals from 10 European countries. Level of evidence and strength of recommendation were determined for each point to consider, and the mean level of agreement among the task force members was calculated.

Results

Two overarching principles and seven points to consider were formulated based on scientific evidence and the expert opinion of the task force. The two overarching principles focus on shared decisions between patients and non-physician health professionals and involvement of different non-physician health professionals in prevention and management of fragility fractures. Four points to consider relate to prevention: identification of patients at risk of fracture, fall risk evaluation, multicomponent interventions to prevent primary fracture and discouragement of smoking and overuse of alcohol.

The remaining three focus on management of fragility fractures: exercise and nutritional interventions, the organisation and coordination of multidisciplinary services for post-fracture models of care and adherence to anti-osteoporosis medicines. The mean level of agreement among the task force for the overarching principles and the points to consider ranged between 8.4 and 9.6.

Conclusion

These first EULAR points to consider for non-physician health professionals to prevent and manage fragility fractures in adults 50 years or older serve to guide healthcare practice and education.

Publication and source details

Original title: 2019 EULAR points to consider for non-physician health professionals to prevent and manage fragility fractures in adults 50 years or older

Jo Adams; Nicky Wilson; Emalie Hurkmans; Margot Bakkers; Petra Balážová; Mark Baxter; Anne-Birgitte Blavnsfeldt; Karine Briot; Catharina Chiari; Cyrus Cooper; Razvan Gabriel Dragoi; Gabriele Gäbler; Willem Lems; Erika Mosor; Sandra Pais; Cornelia Simon; Paul Studenic; Simon Tilley; Jenny de la Torre-Aboki; Tanja A Stamm

Annals of the Rheumatic Diseases · 2021

Correspondence to Professor Tanja A Stamm, Section for Outcomes Research, Centre for Medical Statistics, Informatics, and Intelligent Systems, Medical University of Vienna, Spitalgasse 23, 1090 Vienna, Austria; tanja.stamm@meduniwien.ac.at

JA and NW are joint first authors.

© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY. Published by BMJ.2021https://creativecommons.org/licenses/by/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/.http://dx.doi.org/10.13039/501100008741European League Against RheumatismHPR-032

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-12T17:49:27.036076+00:00

DOI: 10.1136/annrheumdis-2020-216931 · PMC7788058